Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

por Goure, William F, Krafft, Grant A, Jerecic, Jasna, Hefti, Franz
Publicado 2014

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

por Krafft, Grant A., Jerecic, Jasna, Siemers, Eric, Cline, Erika N.
Publicado 2022

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

por Wang, Xueying, Kastanenka, Ksenia V., Arbel-Ornath, Michal, Commins, Caitlin, Kuzuya, Akira, Lariviere, Amanda J., Krafft, Grant A., Hefti, Franz, Jerecic, Jasna, Bacskai, Brian J.
Publicado 2018